VCTR Q1 2026 Earnings EPS Beats Estimates Amid Strong Operating Performance ASO Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Resilience BOF Q1 2026 Earnings EPS Loss of 012 Amid Operational Challenges Interparfums Inc Q1 2026 Earnings EPS Surpasses Estimates Stock Rises Dianthus Therapeutics Q1 2026 Earnings BetterthanExpected Loss Despite No Revenue Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up